Panbela Therapeutics Inc (PBLA)
0.3798
-0.01
(-1.99%)
USD |
OTCM |
May 10, 16:00
Panbela Therapeutics 1 Year Total Returns (Daily): -99.84% for May 10, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 10, 2024 | -99.84% |
May 09, 2024 | -99.84% |
May 08, 2024 | -99.87% |
May 07, 2024 | -99.85% |
May 06, 2024 | -99.84% |
May 03, 2024 | -99.86% |
May 02, 2024 | -99.86% |
May 01, 2024 | -99.85% |
April 30, 2024 | -99.87% |
April 29, 2024 | -99.87% |
April 26, 2024 | -99.88% |
April 25, 2024 | -99.83% |
April 24, 2024 | -99.84% |
April 23, 2024 | -99.85% |
April 22, 2024 | -99.83% |
April 19, 2024 | -99.87% |
April 18, 2024 | -99.87% |
April 17, 2024 | -99.84% |
April 16, 2024 | -99.85% |
April 15, 2024 | -99.84% |
April 12, 2024 | -99.82% |
April 11, 2024 | -99.78% |
April 10, 2024 | -99.79% |
April 09, 2024 | -99.74% |
April 08, 2024 | -99.75% |
Date | Value |
---|---|
April 05, 2024 | -99.72% |
April 04, 2024 | -99.75% |
April 03, 2024 | -99.77% |
April 02, 2024 | -99.79% |
April 01, 2024 | -99.79% |
March 28, 2024 | -99.77% |
March 27, 2024 | -99.78% |
March 26, 2024 | -99.79% |
March 25, 2024 | -99.79% |
March 22, 2024 | -99.80% |
March 21, 2024 | -99.79% |
March 20, 2024 | -99.78% |
March 19, 2024 | -99.79% |
March 18, 2024 | -99.80% |
March 15, 2024 | -99.85% |
March 14, 2024 | -99.84% |
March 13, 2024 | -99.85% |
March 12, 2024 | -99.84% |
March 11, 2024 | -99.82% |
March 08, 2024 | -99.87% |
March 07, 2024 | -99.85% |
March 06, 2024 | -99.78% |
March 05, 2024 | -99.78% |
March 04, 2024 | -99.78% |
March 01, 2024 | -99.79% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.90%
Minimum
Aug 11 2023
284.6%
Maximum
Jul 14 2020
-36.89%
Average
-56.08%
Median
Jul 20 2022
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -91.80% |
Palatin Technologies Inc | 3.15% |
iBio Inc | -91.27% |
Theriva Biologics Inc | -48.91% |
Oragenics Inc | -39.22% |